Harvest One (CVE:HVT) Launches Satipharm Reformulated CBD Capsules in Europe
Perth, Jan 30, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is pleased to note the attached announcement by Harvest One Cannabis Inc. (CVE:HVT) (HRVOF:OTCMKTS) ("Harvest One") confirming that it has launched European sales of its recently reformulated Satipharm CBD capsules.
MMJ owns 55,557,994 shares in Harvest One for a 30.5% shareholding.
To view the announcement, please visit:
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/